SBI Holdings, Inc. SBI Holdings, Inc.

SBI Holdings, Inc.

8473

Rang in aandelen #1687
SBI Holdings, Inc. is a Japanese conglomerate primarily engaged in online... SBI Holdings, Inc. is a Japanese conglomerate primarily engaged in online financial services and strategic investments, both domestically and internationally. Its operations are structured around three key pillars: Financial Services, Asset Management, and the Biotechnology, Healthcare, and Medical Informatics sectors. The company provides a comprehensive suite of financial products, including online brokerage, investment banking, and internet banking facilities. It offers various insurance solutions such as automobile, health (cancer), property (fire, earthquake), and life coverage, alongside short-term insurance. Further financial offerings encompass foreign exchange (FX) margin trading, online securities, and services related to digital asset exchange and transactions. SBI also manages defined-contribution pension schemes, provides leasing and lending services, and operates a proprietary trading system. Its involvement extends to e-commerce settlement processing, remittance services, and essential back-office support. Beyond traditional banking, SBI is active in private equity and venture capital fund management, offers mergers and acquisitions (M&A) advisory, and runs savings and commercial banking operations. It provides investment advisory and management services, alongside rating information services. The firm also deals with real estate-secured loans and offers rent guarantees for residential properties. In the biotechnology and healthcare domain, SBI conducts research, manufactures, and distributes pharmaceutical products, health supplements, and cosmetics. It develops, produces, sells, and maintains integrated medical information systems. Furthermore, it's involved in the research and development of advanced antibody and nucleic acid drugs targeting cancer and immunological conditions. The company's diverse portfolio includes operating a fund-raising platform, serving as a crypto-asset broker, and developing, manufacturing, and selling crypto-asset mining systems. It also develops and manages cybersecurity systems, provides blockchain platforms, invests in real estate, and engages in used car exports. Additionally, SBI offers healthcare services, participates in revitalization projects, mines digital assets, and is involved in e-sports and renewable energy initiatives. Established in 1999, the company was initially known as Softbank Investment Corporation before adopting its current name, SBI Holdings, Inc., in July 2005. Its headquarters are located in Tokyo, Japan.
Aandeelprijs
$19.65
Marktkapitalisatie
$12.70B
Verandering (1 dag)
1.35%
Verandering (1 jaar)
-11.82%
Land
JP
Handel SBI Holdings, Inc. (8473)

Categorie

Financial Services
P/E-ratio voor SBI Holdings, Inc. (8473)
P/E-ratio op October 2026 TTM: 3.95
Volgens de meest recente financiële rapporten en aandelenkoers van SBI Holdings, Inc. is de huidige P/E-ratio (TTM) 3.95. Eind 2024 had het bedrijf een P/E van 12.01.
Historiek van P/E-ratio voor SBI Holdings, Inc. van 2005 tot 2026
P/E-ratio aan het einde van elk jaar
Jaar P/E-verhouding Wijzigen
2026 (TTM) 3.95 -46.87%
2025 7.43 -38.13%
2024 12.01 -38.73%
2023 19.60 847.49%
2022 2.07 -76.57%
2021 8.83 -8.70%
2020 9.67 -18.92%
2019 11.93 -3.49%
2018 12.36 26.91%
2017 9.74 37.02%
2016 7.11 3.08%
2015 6.89 -45.11%
2014 12.56 -76.55%
2013 53.56 -0.19%
2012 53.66 20.98%
2011 44.36 -66.27%
2010 131.51 -1,690.59%
2009 -8.27 -112.99%
2008 63.67 475.51%
2007 11.06 -16.72%
2006 13.28 21.88%
2005 10.90 0.00%
P/E-ratio voor vergelijkbare bedrijven of concurrenten
Hoe lees je een P/E-ratio?

De koers-winstverhouding (P/E Ratio) meet de relatie tussen de aandelenprijs van een bedrijf en de winst per aandeel.
Een lage maar positieve P/E duidt op een bedrijf dat hoge winsten genereert ten opzichte van zijn huidige waardering en mogelijk ondergewaardeerd is. Een bedrijf met een hoge negatieve (dicht bij 0) P/E lijdt grote verliezen.

Bedrijven met een P/E boven 30 of een negatieve waarde worden meestal gezien als "groeiaandelen", wat betekent dat beleggers verwachten dat het bedrijf zal groeien of winstgevend zal worden.

Bedrijven met een positieve P/E onder de 10 worden meestal gezien als "waardeaandelen", wat betekent dat ze al zeer winstgevend zijn, maar weinig groei wordt verwacht.